장티푸스 항체 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Typhoid Antibody Testing Market size is expected to reach USD 4.92 Billion in 2034 from USD 1.79 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The Global Typhoid Antibody Testing Market is growing steadily due to rising incidence of typhoid fever in developing regions. Accurate and rapid diagnostic testing is essential for timely treatment and disease control. Increasing awareness about infectious disease prevention is supporting market growth.

Key growth drivers include advancements in rapid diagnostic kits and laboratory-based immunoassays. Public health initiatives promoting early detection and vaccination programs are strengthening demand. Expanding healthcare access in rural areas is also contributing to higher testing rates. Additionally, government support for infectious disease surveillance is supporting market expansion.

Looking ahead, the market is expected to benefit from improved test sensitivity and point-of-care solutions. Emerging economies investing in healthcare infrastructure will present new opportunities. Companies are focusing on cost-effective and easy-to-use testing kits. As infectious disease monitoring remains critical, the Global Typhoid Antibody Testing Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serologic Tests
• Nucleic Acid Amplification Tests
• Polymerase Chain Reaction Tests

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Rapid Diagnostic Tests
• Western Blotting

By End User

• Hospitals
• Reference Laboratories
• Diagnostic Centers
• Homecare Testing

By Sample Type

• Blood Samples
• Serum Samples
• Plasma Samples

By Application

• Clinical Diagnosis
• Research and Development
• Epidemiological Studies

COMPANIES PROFILED

• Abbott Laboratories, BioRad Laboratories, Diagnostic BioSystems, HoffmannLa Roche, Hycult Biotech, Medmix, Zhejiang Dian Diagnostics, VivaDiag, Roche Holding, Siemens Healthineers, Grifols, Meridian Bioscience, Wako Pure Chemical Industries, Thermo Fisher Scientific, Adaltis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serologic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Nucleic Acid Amplification Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Polymerase Chain Reaction Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rapid Diagnostic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Western Blotting Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Homecare Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. Blood Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Serum Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Plasma Samples Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Clinical Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Epidemiological Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL TYPHOID ANTIBODY TESTING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Type
  • 9.2.2 By Technology
  • 9.2.3 By End User
  • 9.2.4 By Sample Type
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Type
  • 9.3.2 By Technology
  • 9.3.3 By End User
  • 9.3.4 By Sample Type
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Type
  • 9.4.2 By Technology
  • 9.4.3 By End User
  • 9.4.4 By Sample Type
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Type
  • 9.5.2 By Technology
  • 9.5.3 By End User
  • 9.5.4 By Sample Type
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Type
  • 9.6.2 By Technology
  • 9.6.3 By End User
  • 9.6.4 By Sample Type
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL TYPHOID ANTIBODY TESTING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 BioRad Laboratories
  • 11.2.3 Diagnostic BioSystems
  • 11.2.4 Hoffmann-La Roche
  • 11.2.5 Hycult Biotech
  • 11.2.6 Medmix
  • 11.2.7 Zhejiang Dian Diagnostics
  • 11.2.8 VivaDiag
  • 11.2.9 Roche Holding
  • 11.2.10 Siemens Healthineers
  • 11.2.11 Grifols
  • 11.2.12 Meridian Bioscience
  • 11.2.13 Wako Pure Chemical Industries
  • 11.2.14 Thermo Fisher Scientific
  • 11.2.15 Adaltis